Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity

Archives of Pharmacal Research

Volumn 34, Issue 5, 2011, Pages 821-828

  Fouad, Amr A ^a   Yacoubi, Mohamed T ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Capsazepine; Cardiotoxicity; Doxorubicin; Eugenol; Rats

Indexed keywords

CALCIUM; CAPSAZEPINE; CASPASE 3; CREATINE KINASE; DOXORUBICIN; EUGENOL; LACTATE DEHYDROGENASE; LIPID; NITRIC OXIDE; VANILLOID RECEPTOR 1 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG ACTIVITY; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CALCIUM SIGNALING; CAPSAICIN; CARDIOTONIC AGENTS; CARDIOTOXINS; CASPASE 3; DOXORUBICIN; EUGENOL; HEART; HEART FAILURE; LIPID PEROXIDATION; MALE; MYOCARDIUM; NITRIC OXIDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TRPV CATION CHANNELS;

EID: 79960227106     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0516-2     Document Type: Article

References (31)

1. S. K. Abraham 2001 Anti-genotoxicity of trans-anethole and eugenol in mice Food Chem. Toxicol. 39 493 498 11313116 10.1016/S0278-6915(00)00156-3 1:CAS:528:DC%2BD3MXislGhu7Y%3D (Pubitemid 32323983)
2. I. Andreadou F. Sigala E. K. Iliodromitis M. Papaefthimiou C. Sigalas N. Aligiannis P. Savvari V. Gorgoulis E. Papalabros D. T. Kremastinos 2007 Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress J. Mol. Cell. Cardiol. 42 549 558 17223128 10.1016/j.yjmcc.2006.11.016 1:CAS:528: DC%2BD2sXislKgsr8%3D (Pubitemid 46357553)
3. J. L. Burkey J. M. Sauer C. A. McQueen I. G. Sipes 2000 Cytotoxicity and genotoxicity of methyleugenol and related congeners-a mechanism of activation for methyleugenol Mutat. Res. 453 25 33 11006409 1:CAS:528:DC%2BD3cXmslyisb8%3D
4. C. Y. Choi K. R. Park J.-.H. Lee Y. J. Jeon K. H. Liu S. Oh D. E. Kim S. S. Yea 2007 Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-B, ERK1/2, and p38 kinase Eur. J. Pharmacol. 576 151 159 17698059 10.1016/j.ejphar.2007.07.034 1:CAS:528:DC%2BD2sXhtF2ms7nM (Pubitemid 47588244)
5. R. Choudhary K. P. Mishra C. Subramanyam 2006 Interrelations between oxidative stress and calcineurin in the attenuation of cardiac apoptosis by eugenol Mol. Cell. Biochem. 283 115 122 16444593 10.1007/s11010-006-2386-3 1:CAS:528:DC%2BD28XovVCjsA%3D%3D
6. A. Franco-Cereceda A. Saria J. M. Lundberg 1989 Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain Acta Physiol. Scand. 135 173 187 2784250 10.1111/j.1748-1716.1989.tb08565.x 1:CAS:528:DyaL1MXhsVynsr4%3D (Pubitemid 19058579)
7. R. Huang A. Karve I. Shah M. C. Bowers D. J. DiPette S. C. Supowit G. S. Abela 2008 Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 294 H1291 H1297 18192222 10.1152/ajpheart.00749. 2007 1:CAS:528:DC%2BD1cXjsFymtrs%3D (Pubitemid 351468726)
8. B. Jiang L. Zhang M. Li W. Wu M. Yang J. Wang D.-a. Guo 2008 Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress Food Chem. Toxicol. 46 1510 1515 18234414 10.1016/j.fct.2007. 12.020 1:CAS:528:DC%2BD1cXjs1Kiurg%3D
9. M. Ito K. Murakami M. Yoshino 2005 Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation Food Chem. Toxicol. 43 461 466 15680683 10.1016/j.fct.2004.11.019 1:CAS:528: DC%2BD2MXos1Sgtw%3D%3D (Pubitemid 40170480)
10. H. Kabuto M. Tada M. Kohno 2007 Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum Biol. Pharm. Bull. 30 423 427 17329831 10.1248/bpb.30.423 1:CAS:528:DC%2BD2sXkvVSnt78%3D (Pubitemid 46355914)
11. E. C. Keung L. Toll M. Ellis R. A. Jensen 1991 L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations J. Clin. Invest. 87 2108 2113 1645752 10.1172/JCI115241 1:CAS:528:DyaK3MXks1Ciu78%3D
12. 2+ increase are reciprocally modulated in rat cardiomyocytes Exp. Mol. Med. 38 535 545 17079870 1:CAS:528:DC%2BD28XhtF2qsL7J
13. + currents in trigeminal ganglion neurons J. Dent. Res. 86 898 902 17720863 10.1177/154405910708600918 1:CAS:528:DC%2BD2sXhtVOqurfE
14. W. Li R. Tsubouchi S. Qiao M. Haneda K. Murakami M. Yoshino 2006 Inhibitory action of eugenol compounds on the production of nitric oxide in RAW264.7 macrophages Biomed. Res. 27 69 74 16707845 10.2220/biomedres.27.69
15. Y. J. Li J. Peng 2002 The cardioprotection of calcitonin gene-related peptide-mediated preconditioning Eur. J. Pharmacol. 442 173 177 12065069 10.1016/S0014-2999(02)01538-8 1:CAS:528:DC%2BD38XksVShs7o%3D (Pubitemid 34626191)
16. J. Magyar N. Szentandrássy T. Bányász L. Fülöp A. Varró P. P. Nánási 2004 Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes Eur. J. Pharmacol. 487 29 36 15033373 10.1016/j.ejphar.2004.01. 011 1:CAS:528:DC%2BD2cXitFeiuro%3D (Pubitemid 38368979)
17. S. Manzini F. Perretti L. De Benedetti P. Pradelles C. A. Maggi P. Geppetti 1989 A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release Br. J. Pharmacol. 97 303 312 2474343 1:CAS:528:DyaL1MXltV2ksL0%3D (Pubitemid 19142731)
18. G. Minotti P. Menna E. Salvatorelli G. Cairo L. Gianni 2004 Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol. Rev. 56 185 229 15169927 10.1124/pr.56.2.6 1:CAS:528:DC%2BD2cXltlKgtb0%3D (Pubitemid 38720829)
19. T. Mizutani K. Satoh H. Nomura 1991 Hepatotoxicity of eugenol and related compounds in mice depleted of glutathione: structural requirements for toxic potency Res. Commun. Chem. Pathol. Pharmacol. 73 87 95 1882130 1:CAS:528:DyaK3MXmtVSms7o%3D
20. M. A. Morsy A. A. Fouad 2008 Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats Phytother. Res. 22 1361 1366 18543354 10.1002/ptr.2502 1:CAS:528:DC%2BD1cXhsVaqt73E
21. E. Nagababu B. Sesikeran N. Lakshmaiah 1995 The protective effects of eugenol on carbon tetrachloride induced hepatotoxicity in rats Free Radic. Res. 23 617 627 8574354 10.3109/10715769509065281 1:CAS:528:DyaK28Xis1yisw%3D%3D
22. H. C. Ou F. P. Chou T. M. Lin C. H. Yang W. H.-H. Sheu 2006 Protective effects of eugenol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells Food Chem. Toxicol. 44 1485 1495 16762475 10.1016/j.fct.2006.04.011 1:CAS:528:DC%2BD28Xmsl2isLY%3D (Pubitemid 43994281)
23. P. Pacher L. Liaudet P. Bai J. G. Mabley P. M. Kaminski L. Virág A. Deb E. Szabó Z. Ungvári M. S. Wolin J. T. Groves C. Szabó 2003 Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction Circulation 107 896 904 12591762 10.1161/01.CIR.0000048192.52098.DD 1:CAS:528:DC%2BD3sXht1Cmsb0%3D (Pubitemid 36241050)
24. M. M. Sayed-Ahmed M. M. Khattab M. Z. Gad A. M. Osman 2001 Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy Pharmacol. Toxicol. 89 140 144 11589785 10.1034/j.1600-0773.2001. d01-148.x 1:CAS:528:DC%2BD3MXnsVensbs%3D
25. P. K. Singal N. Iliskovic 1998 Doxorubicin-induced cardiomyopathy N. Engl. J. Med. 339 900 905 9744975 10.1056/NEJM199809243391307 1:STN:280:DyaK1cvhsVektw%3D%3D (Pubitemid 28446849)
26. G. Singh A. T. Singh A. Abraham B. Bhat A. Mukherjee R. Verma S. K. Agarwal S. Jha R. Mukherjee A. C. Burman 2008 Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity J. Ethnopharmacol. 117 123 129 18346858 10.1016/j.jep.2008.01.022
27. D. C. Thompson D. Constantin-Teodosiu P. Moldéus 1991 Metabolism and cytotoxicity of eugenol in isolated rat hepatocytes Chem. Biol. Interact. 77 137 147 1991333 10.1016/0009-2797(91)90069-J 1:CAS:528:DyaK3MXhsFyksbc%3D
28. D. C. Thompson R. Barhoumi R. C. Burghardt 1998 Comparative toxicity of eugenol and its quinone methide metabolite in cultured liver cells using kinetic fluorescence bioassays Toxicol. Appl. Pharmacol. 149 55 63 9512727 10.1006/taap.1997.8348 1:CAS:528:DyaK1cXhs1alsr0%3D (Pubitemid 28105572)
29. A. B. Tiku S. K. Abraham R. K. Kale 2004 Eugenol as an in vivo radioprotective agent J. Radiat. Res. 45 435 440 15613789 10.1269/jrr.45.435 1:CAS:528:DC%2BD2MXisVOqsb8%3D (Pubitemid 40254072)
30. L. Wang C. P. Hu P. Y. Deng S. S. Shen H. Q. Zhu J. S. Ding G. S. Tan Y. J. Li 2005 The protective effects of rutaecarpine on gastric mucosa injury in rats Planta Med. 71 416 419 15931578 10.1055/s-2005-864135 1:CAS:528: DC%2BD2MXlsFemtbY%3D (Pubitemid 40839773)
31. B. H. Yang Z. G. Piao Y.-B. Kim C.-H. Lee J. K. Lee K. Park J. S. Kim S. B. Oh 2003 Activation of vanilloid receptor 1 (VR1) by eugenol J. Dent. Res. 82 781 785 14514756 10.1177/154405910308201004 1:CAS:528:DC%2BD3sXosFCks78%3D (Pubitemid 41766107)